Time-to-Treatment Effects of Sociodemographic Patient Factors in Early-Stage Non–Small Cell Lung Cancer
Journal of Surgical Research · 2026-05 · 321 · 37-44
DOI: 10.1016/j.jss.2026.02.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Research, 2026-05. Verfasst von Jonathan E Williams und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Michigan, Ann Arbor, Michigan; Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, Mic…. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Time-to-Treatment, Healthcare Disparities. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Foundation for the National Institutes of Health.
Abstract (Originalsprache)
INTRODUCTION Lung cancer causes the most cancer-related deaths in the United States. For patients with localized disease, expeditious treatment portends improved outcomes. This study explores relationships between patient factors and timely treatment for early-stage non-small cell lung cancer (NSCLC) in a population-based cancer registry. METHODS All adult patients with localized NSCLC between January 1, 2015, and December 31, 2021, were identified through the Michigan Cancer Surveillance Program. Demographic and social factors were compared between treatment groups. Time-to-treatment was defined as days between diagnosis and initiation of first treatment. Multivariable Poisson regression was used to compare time-to-treatment across race, payer, and rural-urban continuum groups. Subset analysis stratifying by first treatment modality was performed. RESULTS A total of 10,618 patients with NSCLC were included, with 4753 undergoing operative resection, 5151 undergoing radiation therapy, and 894 undergoing systemic therapy. Overall mean time-to-treatment was 59.8 d (standard deviation [SD], 34.4), with time-to-surgery 57.4 d (SD, 32.9), time-to-radiation therapy 63.0 d (SD, 35.5), and time-to-systemic therapy 53.4 d (SD, 33.7). Adjusted time-to-treatment was longer in Black patients compared to White patients (incidence rate ratio [IRR]: 1.14, 95% confidence interval [CI]: 1.13-1.15, P < 0.001), longer in Medicaid patients compared to Medicare patients (IRR: 1.07, 95% CI: 1.06-1.09, P < 0.001), and shorter in patients in suburban areas compared to urban areas (IRR: 0.95, 95% CI: 0.94-0.97, P < 0.001). Subset analysis of patients undergoing operative resection yielded similar trends. CONCLUSIONS Sociodemographic factors, including race, payer, and geography, may influence treatment wait times for patients with NSCLC. This inspires further investigation of systems-based drivers of timely treatment and equitable cancer care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of Michigan, Ann Arbor, Michigan; Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, Michigan. Electronic address: willjona@med.umich.edu.
- Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, Michigan.
- Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
- Department of Surgery, University of Michigan, Ann Arbor, Michigan; Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, Michigan.
Förderung
- Foundation for the National Institutes of Health
Zitieren
APA
Williams, J. E., Jacobson-Davies, F., Jacobs, R. C., & Odell, D. D. (2026). Time-to-Treatment Effects of Sociodemographic Patient Factors in Early-Stage Non–Small Cell Lung Cancer. Journal of Surgical Research, 321, 37-44. https://doi.org/10.1016/j.jss.2026.02.021
Vancouver
Williams JE, Jacobson-Davies F, Jacobs RC, Odell DD. Time-to-Treatment Effects of Sociodemographic Patient Factors in Early-Stage Non–Small Cell Lung Cancer. Journal of Surgical Research. 2026;321:37-44. doi:10.1016/j.jss.2026.02.021
BibTeX
@article{Williams2026,
author = {Williams, Jonathan E and Jacobson-Davies, Faelan and Jacobs, Ryan C and Odell, David D},
title = {Time-to-Treatment Effects of Sociodemographic Patient Factors in Early-Stage Non–Small Cell Lung Cancer},
journal = {Journal of Surgical Research},
year = {2026},
volume = {321},
pages = {37--44},
doi = {10.1016/j.jss.2026.02.021}
}
EUVIMED